The economic burden of physical inactivity: a global analysis of major non-communicable diseases

The Lancet

Volumn 388, Issue 10051, 2016, Pages 1311-1324

  Ding, Ding ^a,b   Lawson, Kenny D ^b,c   Kolbe Alexander, Tracy L ^d,e   Finkelstein, Eric A ^f   Katzmarzyk, Peter T ^g   van Mechelen, Willem ^d,e,h,i   Pratt, Michael ^j  

^a UNIVERSITY OF SYDNEY   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f DUKE UNIVERSITY   (United States)

^g PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY COLLEGE DUBLIN   (Ireland)

^j EMORY UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; BREAST CANCER; CARIBBEAN; CEREBROVASCULAR ACCIDENT; COLON CANCER; EUROPE; HEALTH CARE COST; HIGH INCOME COUNTRY; HUMAN; ISCHEMIC HEART DISEASE; LOWEST INCOME GROUP; META ANALYSIS (TOPIC); MIDDLE INCOME COUNTRY; MIDDLE INCOME GROUP; MORTALITY; NON COMMUNICABLE DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORTH AMERICA; ORGANIZATION AND MANAGEMENT; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; SOUTH AND CENTRAL AMERICA; SOUTHERN EUROPE; CHRONIC DISEASE; COST OF ILLNESS; GLOBAL HEALTH; PREMATURE MORTALITY;

CHRONIC DISEASE; COST OF ILLNESS; DIABETES MELLITUS, TYPE 2; GLOBAL HEALTH; HEALTH CARE COSTS; HUMANS; MORTALITY, PREMATURE; QUALITY-ADJUSTED LIFE YEARS;

EID: 84979763291     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30383-X     Document Type: Article

References (26)

1. 1 Merkur, S, Sassi, F, McDaid, D, Promoting health, preventing disease: is there an economic case?, 2013, World Health Organization Regional Office for Europe, Copenhagen http://www.euro.who.int/__data/assets/pdf_file/0004/235966/e96956.pdf?ua=1 (accessed Nov 6, 2015).
2. 2 Davis, JC, Verhagen, E, Bryan, S, et al. 2014 consensus statement from the first Economics of Physical Inactivity Consensus (EPIC) conference (Vancouver). Br J Sports Med 48 (2014), 947–951.
3. 3 Kohl, HW 3rd, Craig, CL, Lambert, EV, et al. The pandemic of physical inactivity: global action for public health. Lancet 380 (2012), 294–305.
4. 4 Lee, IM, Shiroma, EJ, Lobelo, F, Puska, P, Blair, SN, Katzmarzyk, PT, Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380 (2012), 219–229.
5. 5 Pratt, M, Norris, J, Lobelo, F, Roux, L, Wang, G, The cost of physical inactivity: moving into the 21st century. Br J Sports Med 48 (2014), 171–173.
6. 6 Abegunde, DO, Mathers, CD, Adam, T, Ortegon, M, Strong, K, The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370 (2007), 1929–1938.
7. 7 Hallal, PC, Andersen, LB, Bull, FC, Guthold, R, Haskell, W, Ekelund, U, Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet 380 (2012), 247–257.
8. 8 Scarborough, P, Bhatnagar, P, Wickramasinghe, KK, Allender, S, Foster, C, Rayner, M, The economic burden of ill health due to diet, physical inactivity, smoking, alcohol and obesity in the UK: an update to 2006–07 NHS costs. J Public Health 33 (2011), 527–535.
9. 9 Physical Activity Guidelines Advisory Committee. Physical Activity Guidelines Advisory Committee report, 2008, 2008, US Department of Health and Human Services, Washington, DC.
10. 10 Wendel-Vos, GC, Schuit, AJ, Feskens, EJ, et al. Physical activity and stroke. A meta-analysis of observational data. Int J Epidemiol 33 (2004), 787–798.
11. 11 WHO. Global recommendations on physical activity for health, 2010, World Health Organization, Geneva.
12. 12 Sallis, JF, Bull, F, Guthold, R, et al., for the Lancet Physical Activity Series 2 Working Group. Progress in physical activity over the Olympic quadrennium. Lancet, 2016 published online July 27. http://dx.doi.org/10.1016/S0140-6736(16)30581-5.
13. 13 Global Burden of Disease Study Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
14. 14 Allemani, C, Weir, HK, Carreira, H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385 (2015), 977–1010.
15. 15 Daneman, D, Type 1 diabetes. Lancet 367 (2006), 847–858.
16. 16 International Diabetes Federation. IDF Diabetes Atlas, 6th edn., 2013, International Diabetes Federation, Brussels.
17. 17 Zhang, P, Zhang, X, Brown, J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87 (2010), 293–301.
18. 18 Luengo-Fernandez, R, Leal, J, Gray, A, Sullivan, R, Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14 (2013), 1165–1174.
19. 19 Leal, J, Luengo-Fernandez, R, Gray, A, Economic Costs. Nichols, M, Townsend, N, Scarborough, P, et al. (eds.) European Cardiovascular Disease Statistics, 2012, European Heart Network, Brussels European Society of Cardiology, Sophia Antipolis.
20. 20 Economist Intelligence Unit. Breakaway: the global burden of cancer–challenges and opportunities. http://graphics.eiu.com/upload/eb/EIU_LIVESTRONG_Global_Cancer_Burden.pdf, 2009 (accessed Sept 30, 2015).
21. 21 Bloom, DE, Cafiero, ET, Jané-Llopis, E, et al. The global economic burden of noncommunicable diseases, 2011, World Economic Forum, Geneva.
22. 22 Sarwar, N, Gao, P, Seshasai, SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375 (2010), 2215–2222.
23. 23 Koopmanschap, MA, Rutten, FF, van Ineveld, BM, van Roijen, L, The friction cost method for measuring indirect costs of disease. J Health Econ 14 (1995), 171–189.
24. 24 The World Bank. GDP per capita, PPP (current international $). http://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD, 2015 (accessed Sept 30, 2015).
25. 25 Murray, CJ, Barber, RM, Foreman, KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386 (2015), 2145–2191.
26. 26 Craig, CL, Marshall, AL, Sjöström, M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35 (2003), 1381–1395.